Two manufacturing sites of Qilu were approved by UK MHRA
Release time:
2014-12-04
Two auditors of UK MHRA inspected Qilu Tianhe Pharmaceutical Co., Ltd and Qilu Antibiotics Co., Ltd. During Nov. 17 to 21, 2014. Both sites were approved without key discrepancy which means the capacity of Tianhe and Antibiotics are recognized by MHRA and strengthen the foundation of extending international market continuously for Qilu.
Related News
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail:export@qilu-pharma.com, FDF@qilu-pharma.com
0531-83126666
wangzhan@qilu-pharma.com